Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors Phase II, m
- This topic has 0 replies, 1 voice, and was last updated 4 years, 8 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors Phase II, multi-center, open-label study of patients with advanced solid tumors harboring a fusion of NTRK1, NTRK2 or NTRK3
https://clinicaltrials.gov/ct2/show/NCT02576431
Gavin
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.